Skip to main content

Table 1 Demographics and other characteristics of the population studied

From: Ampicillin/Sulbactam versus Cefuroxime as antimicrobial prophylaxis for cesarean delivery: a randomized study

Variable Total group
n = 176
Cefuroxime
n = 85 (48.3%)
Ampicillin/Sulbactam
n = 91 (51.7%)
P - value
Age, median (IQR) 28 (24-32) 27 (23.5-31) 28 (24-32) 0.7
Multiparity, n (%) 98 (55.7) 48 (56.5) 50 (54.9) 0.9
BMI ≤24 kg/m2, n (%) 39 (22.2) 18 (21.2) 21 (23.1) 0.9
BMI ≥ 30 kg/m2, n (%) 76 (43.2) 38 (44.7) 38 (41.8) 0.8
Diabetes mellitus, n (%) 7 (4) 3 (3.5) 4 (4.4) 1
Hypertension (including pre-eclampsia)/other cardiovascular condition, n (%) 36 (20.5) 16 (18.8) 20 (22) 0.7
Chronic respiratory disease, n (%) 1 (0.6) 1 (1.2) 0 (0) 0.5
Corticosteroid use, n (%) 2 (1.1) 2 (2.4) 0 (0) 0.2
Creatinine in mg/dL, median (IQR) 0.6 (0.5-0.7) 0.6 (0.5-0.7) 0.6 (0.5-0.7) 0.6
ASA ≥ 2, n (%) 59 (33.5) 27 (31.8) 32 (35.2) 0.7
Regular prenatal f/u, n (%) 167 (94.9) 83 (97.6) 84 (94.4) 0.4
Vaginal examinations, n (%) 96 (54.5) 45 (52.9) 51 (56) 0.8
Vaginal examinations ≥ 6, n (%) 23 (13.1) 11 (12.9) 12 (13.2) 1
Ruptured membranes, n (%) 54 (30.7) 24 (28.2) 30 (33) 0.5
Ruptured membranes ≥ 6 hours, n (%) 9 (5.1) 3 (3.5) 6 (6.6) 0.5
Non-elective emergency cesarean, n (%) 87 (49.4) 42 (49.4) 45 (49.5) 1
General anesthesia 110 (62.5) 50 (58.8) 60 (65.9) 0.4
Duration of surgery >60 minutes, n (%) 111 (63.1) 53 (62.4) 58 (63.7) 0.9
Blood loss >500 ml, n (%) 74 (42) 37 (43.5) 37 (40.7) 0.8
All post-op infections, n (%) 13 (7.4) 5 (5.9) 8 (8.8) 0.6
Post-cesarean endometritis, n (%) 4 (2.3) 2 (2.4) 2 (2.2) 1
Post-cesarean SSI (includes endometritis), n (%) 10 (5.7) 4 (4.7) 6 (6.6) 0.7
Duration of hospitalization in days, median (IQR) 4 (4-4) 4 (4-5) 4 (4-4) 0.09
Duration of hospitalization post-operatively in days, median (IQR) 2 (2-2) 2 (2-2) 2 (2-2) 0.04
  1. BMI: Body mass index, ASA: American society of Anesthesiologists score, Post-op: postoperative, IQR: Interquartile range